Since its discovered function as a ′′don’t-eat-me′′ signal in solid tumors31, CD24 has prompted significant interest as a candidate immunotherapy target in cancer and has been considered as a part of the innate immune checkpoint landscape that influence innate immune activation and response. The gene discussed is CD24; the disease is cancer.